The impact of disease and species differences on the intestinal CLCA4 gene expression
Journal of Molecular Medicine · 2025-06 · 103 (6) · 687-697
DOI: 10.1007/s00109-025-02538-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Molecular Medicine, online erschienen am 12.04.2025. Verfasst von K Teske und 13 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Veterinary Pathology, Faculty of Veterinary Medicine, Freie Universität Berlin, Berlin, Germany. Hauptthemen laut MEDLINE: Chloride Channels, Colitis, Intestinal Mucosa. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Freie Universität Berlin.
Abstract (Originalsprache)
The human chloride channel regulator, calcium-activated (CLCA) 4 is discussed as a driver of epithelial-to-mesenchymal transition as well as a biomarker for colorectal cancer (CRC) and ulcerative colitis. In contrast to humans, the Clca4 gene is duplicated in the mouse, a common model species to study gene functions. However, the relevance of the functional murine Clca4 variants in healthy and diseased intestine is largely unknown. Here, we characterized the spatiotemporal expression patterns of the murine Clca4a and Clca4b genes in the healthy intestinal tract as well as in dextran sulfate sodium (DSS)-induced colitis and colitis-associated colon cancer (CAC) mouse model using RT-qPCR and in situ-hybridization. Similarly, we analyzed expression of the human CLCA4 in healthy, inflamed and cancerous intestinal tracts at single cell level. Murine Clca4a and - 4b but not the human CLCA4 were detected in small intestine enterocytes of the respective species. Conversely, healthy colonocytes expressed the human CLCA4 and its murine ortholog Clca4a but not the murine Clca4b . Under inflammatory conditions, de novo expression of Clca4b was observed with both murine homologs abundantly expressed in enterocytes adjacent to ulcerations. Neoplastic colonocytes expressed none or only minimal amounts of the CLCA4 homologs both in humans and mice, whereas adjacent non-neoplastic colonocytes strongly up-regulated the human or both murine homologs, respectively. Our results suggest marked species- and homolog-specific differences in the expression patterns of the three CLCA4 homologs. Moreover, all three seem to play a role in reactive, non-neoplastic colonocytes adjacent to ulcerated and neoplastic lesions. Key messages Human CLCA4 and murine Clca4a , but not Clca4b , are expressed in healthy colonocytes. Inflammation leads to a de novo expression of the murine Clca4b in colonocytes. Human and murine CLCA4 homologs are absent from neoplastic enterocytes. Human and murine CLCA4 s are highly expressed in tumor-adjacent, reactive colonocytes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Veterinary Pathology, Faculty of Veterinary Medicine, Freie Universität Berlin, Berlin, Germany.
- MF 3 - Animal Experimental Research and 3r - Methods Development, Research Infrastructure and Information Technology, Robert Koch Institute, Berlin, Germany.
- Medical Department of Gastroenterology, Infectious Diseases and Rheumatology, Charité - University Medicine Berlin, Berlin, Germany.
- Pitzer Laboratory of Osteoarthritis Research, German Rheumatism Research Center Berlin, a Leibniz Institute, Berlin, Germany.
- Experimental Immunology and Osteoarthritis Research, Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität Zu Ber…
- Center of Infection Medicine, Institute of Microbiology and Epizootics, Freie Universität Berlin, Berlin, Germany.
Förderung
- Freie Universität Berlin
Zitieren
APA
Teske, K., Erickson, N. A., Huck, A., Dzamukova, M., Fulde, M., Heinbokel, T., Horst, D., Klymiuk, N., Pastille, E., Mekes-Adamczyk, A., Löhning, M., Gruber, A. D., Glauben, R., & Mundhenk, L. (2025). The impact of disease and species differences on the intestinal CLCA4 gene expression. Journal of Molecular Medicine, 103(6), 687-697. https://doi.org/10.1007/s00109-025-02538-9
Vancouver
Teske K, Erickson NA, Huck A, Dzamukova M, Fulde M, Heinbokel T, et al. The impact of disease and species differences on the intestinal CLCA4 gene expression. Journal of Molecular Medicine. 2025;103(6):687-697. doi:10.1007/s00109-025-02538-9
BibTeX
@article{Teske2025,
author = {Teske, K and Erickson, N A and Huck, A and Dzamukova, M and Fulde, M and Heinbokel, T and Horst, D and Klymiuk, N and Pastille, E and Mekes-Adamczyk, A and Löhning, M and Gruber, A D and Glauben, R and Mundhenk, L},
title = {The impact of disease and species differences on the intestinal CLCA4 gene expression},
journal = {Journal of Molecular Medicine},
year = {2025},
volume = {103},
number = {6},
pages = {687--697},
doi = {10.1007/s00109-025-02538-9}
}
EUVIMED